2021 year-end digital health funding: Seismic shifts beneath the surface

A review of 2021’s funding environment with a focus on the underlying changes beneath the surface’s venture stats.

Hindsight is 2021: Looking back and forward at key themes shaping digital health

Reflections and predictions for the new year.

Consumer adoption of telemedicine in 2021

51% of surveyed consumers in 2021 reported prior use of live video telemedicine–eight percentage points higher than in 2020.

10 Years of the Top 50 in Digital Health: Announcing This Year’s Award Winners

Congratulations to all of the winners of this year's Top 50 in Digital Health!

The simplest, most accurate way to find a doctor: Announcing our investment in Ribbon Health

Announcing our investment in Ribbon Health, an API-first platform that simplifies complex healthcare workflow.

Pulse check: An analysis of the FDA’s list of AI- and ML-enabled devices

A look at the FDA’s new database of AI and ML-enabled devices, and an exploration of what can be gleaned from the data.

Q3 2021 digital health funding: To $20B and beyond!

With $6.7B raised across 169 deals in Q3, 2021’s digital health funding stream has now topped $20B.

Building comprehensive women+ digital health: Eight sectors serving women+ needs

From January-August 2021, investors nearly doubled funding for digital health companies that serve women+ individuals compared to all of 2020. Across 26 deals in 2021 (through August), women+ digital health companies secured $1.3B in funding—accounting for 7% of total digital health funding in that time period. This piece segments the women+ digital health market into eight sectors and highlights opportunities for increased investor attention.

Rock Health meets this moment in digital health

Our vision for the digital health industry continues to shape our strategy as a company, pushing us to focus on how we can deliver the greatest impact. That single vision is the animating force behind the three core elements of what make up Rock Health.

Healthcare’s middle children: Potential disruptors flying under the radar

A major potential disruptor in healthcare is flying under the radar. “Middle children'' are large (but not BIG) retail, fitness, and tech companies that are, or should be, eyeing opportunities in healthcare. In this article we argue that middle children have distinct advantages over their big tech and big retail siblings (and their startup younger siblings), and we hypothesize about future healthcare strategies that these players may pursue.